CVC  Mitsui Global Investment

     Office Locations:

535 Middlefield Road, Suite 100
Menlo Park, CA 94025
Phone: 650-234-5000
Fax: 650-323-1516

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Early
  • Expansion
  • Growth
  • Seed



  • Communications & Networking
  • Consumer Products & Services
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Retail & Restaurant
  • Software & Internet



    Mitsui & Co. Global Investment, Inc. is the venture capital arm of Mitsui & Co. Ltd. specializing in investments in seed stage to formation capital, late stage venture to growth capital, and early stage midsized companies. It seeks to invest in Medical Healthcare (pharmaceuticals, medical devices and medical related services), Cleantech (green technology and new energies), IT (internet technology/services, software and electronics) and Consumer Services (food service and retail). Currently, the firm is focused on IT, healthcare, and cleantech industries. MCVP currently manages over $280 million in capital, focusing on early stage investments in U.S., China, Korea and Japan. Mitsui Global Investments was founded in 2001 and is based in New York, with additional offices in Menlo Park, California and Tokyo, Japan.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Masaji Matsuoka Principal
    Masashi Kiyomine Investment Director
    Sanjay Pichaiah Investment Director
    Shin Kodera Managing Director
    Shinya Imai President & CEO


    Portfolio companies include:

        web link

      Actimis Pharmaceuticals
        web link

      Anaeropharma Science
        web link

      ArmaGen Technologies
        web link

        web link

      Axikin Pharmaceuticals
        web link

        web link

      Boingo Wireless
        web link

        web link

        web link

        web link

      Edison Pharmaceuticals
        web link

        web link

      Hainan Hailing Chemipharma

      Infomart International
        web link

        web link

        web link

        web link

        web link

      On-chip Biotechnologies
        web link

      Ooptiscan Biomedical
        web link

        web link

      Pinnacle Engines
        web link

      Protein Simple
        web link

        web link

      QD Laser
        web link

      Redwood Systems
        web link

      Rive Technology
        web link

        web link

      Symic Biomedical
        web link

        web link


    Recent News: